Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.53 |
| ▸ | ESR1 | P03372 | 2/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | TACR2 | P21452 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SHBG | P04278 | 1/20 | 0.43 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2166705 | 0.93 | MAPK1 (0.46) | TYRESR1CYP3A4KDM4EALOX15 | |
| SCHEMBL30081966 | 0.87 | TYR (0.50) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL30081967 | 0.87 | TYR (0.50) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL875815 | 0.87 | CNR1 (0.38) | TYRESR1TP53CYP3A4HIF1A | |
| SCHEMBL10640009 | 0.86 | TYR (0.49) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL8982055 | 0.85 | TYR (0.65) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL10636865 | 0.84 | TYR (0.46) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL9117770 | 0.83 | TYR (0.46) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL10337301 | 0.82 | TYR (0.60) | TYRESR1ADRA2AADORA3TACR2 | |
| SCHEMBL3441358 | 0.82 | TYR (0.60) | TYRESR1ADRA2AADORA3TACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3528776-B1 | REDUCED-ETHANOL MOUTH RINSE FORMULATIONS | KENVUE BRANDS LLC (US) | 2025-11-26 | — | — | EP | disclosed |
| EP-3653303-B1 | PIPETTE TIP RACK | BIOTIX INC (US) | 2025-02-26 | — | — | EP | disclosed |
| US-12201987-B2 | Pipette tip rack | BIOTIX, INC. (US) | 2025-01-21 | — | — | US | disclosed |
| US-11857653-B2 | Method of providing an oral care benefit using a poorly-soluble calcium compound and fluoride | JOHNSON & JOHNSON CONSUMER INC. (US) | 2024-01-02 | — | — | US | disclosed |
| US-11648186-B2 | Coated particles and their uses | JOHNSON & JOHNSON CONSUMER INC. (US) | 2023-05-16 | — | — | US | disclosed |
| US-11590490-B2 | Pipette tips | BIOTIX, INC. (US) | 2023-02-28 | — | — | US | disclosed |
| US-20220331222-A1 | Method of Providing Oral Care Benefits | KENVUE BRANDS LLC | 2022-10-20 | — | — | US | disclosed |
| US-20220226205-A1 | Coated Particles and Their Uses | KENVUE BRANDS LLC | 2022-07-21 | — | — | US | disclosed |
| US-11351103-B2 | Method of providing oral care benefits | JOHNSON & JOHNSON CONSUMER INC. (US) | 2022-06-07 | — | — | US | disclosed |
| US-11291613-B2 | Coated particles and their uses | JOHNSON & JOHNSON CONSUMER INC. (US) | 2022-04-05 | — | — | US | disclosed |
| US-5538715-A | DENTIFRICES WITH ANTIPLAQUE AGENTS FOR MOUTHS WITH HUMECTANTS, SILICA POLISHES AND BACTERICIDES | COLGATE PALMOLIVE COMPANY (US) | 1996-07-23 | — | — | US | disclosed |
| WO-1994026245-A1 | ORAL CARE COMPOSITIONS CONTAINING ZINC OXIDE PARTICLES | CHURCH & DWIGHT CO., INC. (US) | 1994-11-24 | — | — | WO | disclosed |
| CN-1083700-A | Make the continuation method of non newtonian type cream, white shape goods | COLGATE PALMOLIVE CO (US) | 1994-03-16 | — | — | CN | disclosed |
| US-5288480-A | Antiplaque antibacterial oral composition | COLGATE-PALMOLIVE CO. (US) | 1994-02-22 | — | — | US | disclosed |
| CN-1081366-A | Antibacterial antiplaque oral composition | COLGATE PALMOLIVE CO (US) | 1994-02-02 | — | — | CN | disclosed |
| US-5192530-A | Solubilizer, enhancing agent to aid retention, and delivery enhancement | COLGATE-PALMOLIVE COMPANY (US) | 1993-03-09 | — | — | US | disclosed |
| US-5178851-A | Dentifrices treatment with triclosan and carriers | COLGATE-PALMOLIVE COMPANY (US) | 1993-01-12 | — | — | US | disclosed |
| US-5080887-A | Polyphosphate, bactericide | COLGATE-PALMOLIVE COMPANY (US) | 1992-01-14 | — | — | US | disclosed |
| CN-1044047-A | ANTIPLAQUE ANTIBACTERIAL ORAL COMPOSITION | COLGATE PALMOLIVE CO (US) | 1990-07-25 | — | — | CN | disclosed |
| US-4894220-A | WATER AND ALCOHOL SOLVENTS, GLYCOL DERIVATIVES AND ESTERS SOLUTIONS | COLGATE-PALMOLIVE COMPANY (US) | 1990-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11291613-B2 | Coated particles and their uses | CD63, EPCAM, CD44 | TYR 4307/4885ESR1 3787/4885ADRA2A 4047/4885 |
| US-11648186-B2 | Coated particles and their uses | CD63, EPCAM, CD44 | TYR 4307/4885ESR1 3787/4885ADRA2A 4047/4885 |
| US-20220226205-A1 | Coated Particles and Their Uses | CD63, EPCAM, CD44 | TYR 4307/4885ESR1 3787/4885ADRA2A 4047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.